Changes in CASK expression levels may activate the JAK/STAT signaling pathway by affecting the immunity of Macrophages_M2, thereby regulating apoptosis and cell cycle progression in osteosarcoma cells.<h4>Discussion</h4>In conclusion, CASK may be a potential therapeutic target for osteosarcoma patients. Here, SOAT1 is linked to osteosarcoma.